J&J MedTech unveiled its long-awaited Ottava with FDA de novo authorization for the first table-integrated soft-tissue ...

The U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Johnson & Johnson’s OTTAVA™ Robotic ...

While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with “select customers”.

Johnson & Johnson (JNJ) wins FDA's De Novo authorization for the company’s soft tissue robotic system, Ottava. Read more here.

Johnson & Johnson has won U.S. Food and Drug Administration marketing authorization for its Ottava robotic surgical system. J&J on Wednesday said the FDA green light covers Ottava, the world's first ...

Johnson & Johnson (NYSE:JNJ) announced today that it received FDA de novo authorization for its Ottava surgical robot system.

While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery ...

A multidisciplinary group of experts has issued recommendations for managing systemic cancer therapies in patients undergoing ...

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA™ Robotic Surgical System, the world's first table-integrated soft ...

Having performed more than 7,500 complex brain surgeries, Dr. Aaron Cohen-Gadol helped pioneer fluorescence-guided surgical ...

NICE Surgical Solutions Pte Ltd ("NICE Surgical"), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments, has been granted U.S. Patent No. 12,661,097 ...

Endometriosis is a chronic, estrogen-dependent inflammatory condition affecting a substantial proportion of women of ...